Cryoport Inc (CYRX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Cryoport Inc stock (CYRX) is currently trading at $8.15. Cryoport Inc PS ratio (Price-to-Sales) is 2.29. Analyst consensus price target for CYRX is $13.44. WallStSmart rates CYRX as Underperform.
- CYRX PE ratio analysis and historical PE chart
- CYRX PS ratio (Price-to-Sales) history and trend
- CYRX intrinsic value — DCF, Graham Number, EPV models
- CYRX stock price prediction 2025 2026 2027 2028 2029 2030
- CYRX fair value vs current price
- CYRX insider transactions and insider buying
- Is CYRX undervalued or overvalued?
- Cryoport Inc financial analysis — revenue, earnings, cash flow
- CYRX Piotroski F-Score and Altman Z-Score
- CYRX analyst price target and Smart Rating
Cryoport Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Cryoport Inc (CYRX) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, profit margin, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.
Cryoport Inc (CYRX) Key Strengths (3)
Trading below book value, meaning the market prices it less than net assets
Keeps $45 of every $100 in revenue as net profit
100.20% of shares held by major funds and institutions
Supporting Valuation Data
Cryoport Inc (CYRX) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Modest revenue growth at 9.60%
Small-cap company with higher risk but more growth potential
Revenue is fairly priced at 2.29x sales
Supporting Valuation Data
Cryoport Inc (CYRX) Detailed Analysis Report
Overall Assessment
This company scores 45/100 in our Smart Analysis, earning a D+ grade. Out of 8 metrics analyzed, 3 register as strengths (avg 10.0/10) while 5 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, Profit Margin, Institutional Own.. Valuation metrics including Price/Book (0.87) suggest the stock is attractively priced. Profitability is solid with Profit Margin at 44.50%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (2.29) suggest expensive pricing. Growth concerns include Revenue Growth at 9.60%, which may limit upside. Profitability pressure is visible in Return on Equity at -7.51%, Operating Margin at -0.85%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -7.51% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 9.60% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CYRX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CYRX's Price-to-Sales ratio of 2.29x trades at a deep discount to its historical average of 91.27x (13th percentile). The current valuation is 100% below its historical high of 1124.81x set in Feb 2010, and 90% above its historical low of 1.2x in Feb 2025. Over the past 12 months, the PS ratio has expanded from ~1.3x, reflecting growing market expectations outpacing revenue growth.
Compare CYRX with Competitors
Top INTEGRATED FREIGHT & LOGISTICS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Cryoport Inc (CYRX) · INDUSTRIALS › INTEGRATED FREIGHT & LOGISTICS
The Big Picture
Cryoport Inc is a mature, profitable business with steady cash generation. Revenue reached 176M with 10% growth year-over-year. Profit margins are strong at 44.5%, reflecting pricing power and operational efficiency.
Key Findings
Free cash flow is -5M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Volatility is elevated with a beta of 1.74, so expect amplified moves relative to the broader market.
Sector dynamics: monitor INTEGRATED FREIGHT & LOGISTICS industry trends, competitive moves, and regulatory changes that could impact Cryoport Inc.
Bottom Line
Cryoport Inc is a well-established business delivering consistent profitability with 44.5% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(14 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 12:57:01 PM
About Cryoport Inc(CYRX)
NASDAQ
INDUSTRIALS
INTEGRATED FREIGHT & LOGISTICS
USA
Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee.